Beijing Scitop Bio-Tech Co.,Ltd.’s Net Profit Rose 2.2% in First Three Quarters of 2022
Listen to the full version

Beijing Scitop Bio-Tech Co.,Ltd. (北京科拓恒通生物技术股份有限公司) (300858.SZ) reported a net profit of 86.7 million yuan in the first three quarters of 2022, up 2.2% year-on-year.
Meanwhile, the company posted 264.1 million yuan in revenue, down 1.6% year-on-year.
At the end of the reporting period, it had 1.1 billion yuan in total assets and 74.8 million yuan in total liabilities, with a liability-to-asset ratio of 7.1%.
This article was automatically produced by Caixin Automation on May 9, 2023.
Download our app to receive breaking news alerts and read the news on the go.
Follow the Chinese markets in real time with Caixin Global’s new stock database.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR



